-
Chitosan-based self-assembled nanocarriers coordinated to cisplatin for cancer treatment
- Back
Metadata
Document Title
Chitosan-based self-assembled nanocarriers coordinated to cisplatin for cancer treatment
Author
Trummer R., Rangsimawong W., Sajomsang W., Kumpugdee-Vollrath M., Opanasopit P., Tonglairoum P.
Name from Authors Collection
Affiliations
Faculty of Pharmaceutical and Chemical Engineering, Beuth Hochschule für Technik Berlin, University of Applied Sciences, Berlin, 13353, Germany; Pharmaceutical Development of Green Innovations Group (PDGIG), Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, 73000, Thailand; National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Thailand Science ParkPathum Thani 12120, Thailand
Type
Article
Source Title
RSC Advances
ISSN
20462069
Year
2018
Volume
8
Issue
41
Page
22967-22973
Open Access
Gold
Publisher
Royal Society of Chemistry
DOI
10.1039/C8RA03069C
Abstract
Polymeric nanocarriers were prepared via a dialysis method using three chitosan derivatives, N-benzyl-N,O-succinyl chitosan (BSCT), N-naphthyl-N,O-succinyl chitosan (NSCT), and N-octyl-N-O-succinyl chitosan (OSCT) and were coordinated to cisplatin. The nanocarrier properties and cytotoxicity on the human carcinoma cells, HN22 (head and neck), were investigated. In addition, intracellular cisplatin accumulation, apoptosis induction and toxicity on renal cells were also evaluated. The findings revealed that the succinyl groups of the polymers were perfectly deprotonated and bound with cisplatin by co-ordinate bonds at pH 8.5. Among the derivatives, BSCT exhibited the highest cisplatin loading and release in simulated physiological medium. The cytotoxicities on HN22 cells of cisplatin-loaded BSCT nanocarriers were lower than that of free cisplatin, however, they presented a greater percentage of early apoptosis in HN22 cells and could decrease cisplatin induced renal cell death. In conclusion, the BSCT self-assembly nanocarrier might be a cisplatin carrier for sustained release, which provides prolonged antitumour treatment and reduced nephrotoxicity. © The Royal Society of Chemistry.
Industrial Classification
Knowledge Taxonomy Level 1
Knowledge Taxonomy Level 2
Knowledge Taxonomy Level 3
Funding Sponsor
Thailand Research Fund; Research and Development Institute, Silpakorn University
License
CC BY-NC
Rights
Author
Publication Source
Scopus